Neurology

Indiana University staff discuss their outreach to the Black community and how these efforts could lead to more equitable therapeutic outcomes.

Clinicians discuss the evolving therapeutic landscape for Alzheimer's and offer high expectations for recent clinical trials targeting beta amyloid.

Lifestyle modifications affecting diet, exercise, and cognitive stimulation have been shown to reduce the risk of Alzheimer's brain pathology.

Indiana physicians discuss their research on Alzheimer's patients under age 65, how it differs from late-onset AD, and the implications for therapeutic options.

Doctors discuss how a multidisciplinary approach facilitates integration of imaging technologies, telehealth, and therapeutic advances into MS management.